Skip to content
Back to Guavy Wire
Stocks

Microsoft and Paige Unveil Pathology AI Model with Comprehensive Training Data

Instruments
MSFT
Share

Microsoft Research and Paige have collaborated on a new pathology AI model called PRISM 2. This model is unique in that it's trained on both tissue images and real-world clinical language, allowing it to handle multiple cancer detection, biomarker prediction, and research tasks.

The researchers report that PRISM 2 performs strongly across various pathology benchmarks. Notably, the model has been made available for non-commercial research, which could help push the field forward further.

PRISM 2 is trained on nearly 2.5 million whole-slide images along with their corresponding pathology reports. This comprehensive training data allows the model to learn not only what cancer looks like under a microscope but also how pathologists describe it in clinical language.

More on Stocks

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

© 2026 Guavy Inc